Search results for "Heart failure"
Useful physical exam skills for inpatient assessment
This month's expert discusses measuring vital signs, orthostatic hypertension, and the cardiac exam in the context of inpatient care.
https://immattersacp.org/archives/2023/07/useful-physical-exam-skills-for-inpatient-assessment.htm
1 Jul 2023
Sacubitril-valsartan appears cost-effective in certain heart failure patients
Treatment value was highest in patients with class II heart failure, who also benefited most from treatment in the PARADIGM-HF trial, and improved outcomes with the drug would need to be sustained for at least 36 months to keep the cost per quality-adjusted life-year below a $100,000 threshold.
https://immattersacp.org/weekly/archives/2016/08/30/2.htm
30 Aug 2016
CA-125-guided therapy may improve outcomes for acute heart failure vs. standard of care
A multicenter randomized trial compared postdischarge therapy in patients who were hospitalized for acute heart failure and had high CA-125 levels.
https://immattersacp.org/weekly/archives/2016/08/16/4.htm
16 Aug 2016
Cardiac rehab uptake remains low, despite benefits
Estimates from the American Heart Association suggest that only about 20% to 30% of eligible patients ever receive the intervention.
https://immattersacp.org/archives/2022/03/cardiac-rehab-uptake-remains-low-despite-benefits.htm
1 Mar 2022
AHA evaluates heart failure risks from prescription drugs, OTCs, alternative products
The scientific statement identifies prescription medications that may exacerbate underlying myocardial dysfunction, prescription drugs known to cause direct myocardial toxicity, and the sodium level of some over-the-counter medications, among other concerns.
https://immattersacp.org/weekly/archives/2016/07/19/5.htm
19 Jul 2016
Guideline updated to include new drugs for stage C heart failure with reduced ejection fraction
Among other recommendations, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, or an angiotensin receptor-neprilysin inhibitor, along with a beta-blocker and an aldosterone antagonist, is the new recommended therapy to reduce morbidity and mortality in patients with chronic symptomatic heart failure with reduced ejection fraction.
https://immattersacp.org/weekly/archives/2016/05/24/2.htm
24 May 2016
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2021
Drug interaction risks appear common among older patients being treated for epilepsy
Factors predicting higher drug interaction risk included having one or more comorbid condition versus zero comorbidities, having four or more comorbid conditions versus zero comorbidities, being eligible for the Medicare Part D Low-Income Subsidy, and not living in the northeastern U.S.
https://immattersacp.org/weekly/archives/2018/02/13/4.htm
13 Feb 2018
Palliative care's place outside cancer
Integrated palliative care is important in offering comfort measures to patients with conditions that are expected to shorten their life spans.
https://immattersacp.org/archives/2019/06/palliative-cares-place-outside-cancer.htm
1 Jun 2019
Detecting depression just as important in the elderly
Raising the issue of mental health is key in the elderly, by asking patients how often they talk to other people, if they're getting help with daily activities, or if they are feeling isolated.
https://immattersacp.org/archives/2022/02/detecting-depression-just-as-important-in-the-elderly.htm
1 Feb 2022